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Segmented deep brain stimulation leads feature directional electrodes that allow for
a finer spatial control of electrical stimulation compared to traditional ring-shaped
electrodes. These segmented leads have demonstrated enlarged therapeutic windows
and have thus the potential to improve the treatment of Parkinson’s disease patients.
Moreover, they provide a unique opportunity to record directional local field potentials.
Here, we investigated whether directional local field potentials can help identify the best
stimulation direction to assist device programming. Four Parkinson’s disease patients
underwent routine implantation of the subthalamic nucleus. Firstly, local field potentials
were recorded in three directions for two conditions: In one condition, the patient was at
rest; in the other condition, the patient’s arm was moved. Secondly, current thresholds
for therapeutic and side effects were identified intraoperatively for directional stimulation.
Therapeutic windows were calculated from these two thresholds. Thirdly, the spectral
power of the total beta band (13–35 Hz) and its sub-bands low, high, and peak beta
were analyzed post hoc. Fourthly, the spectral power was used by different algorithms
to predict the ranking of directions. The spectral power profiles were patient-specific,
and spectral peaks were found both in the low beta band (13–20 Hz) and in the high
beta band (20.5–35 Hz). The direction with the highest spectral power in the total
beta band was most indicative of the 1st best direction when defined by therapeutic
window. Based on the total beta band, the resting condition and the moving condition
were similarly predictive about the direction ranking and classified 83.3% of directions
correctly. However, different algorithms were needed to predict the ranking defined by
therapeutic window or therapeutic current threshold. Directional local field potentials
may help predict the best stimulation direction. Further studies with larger sample sizes
are needed to better distinguish the informative value of different conditions and the
beta sub-bands.
Keywords: deep brain stimulation, local field potentials, segmented leads, subthalamic nucleus, Parkinson’s
disease
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INTRODUCTION
Deep brain stimulation (DBS) of the subthalamic nucleus is an
effective therapy for medically refractory cases of Parkinson’s
disease (Deuschl, 2006; Weaver, 2009). Over 100,000 Parkinson’s
disease patients have received a DBS implant (Strauss et al.,
2014). Besides manageable surgical risks, DBS of the subthalamic
nucleus carries the risk of stimulation-induced side effects. Even
though modern stereotactic surgery can achieve sub-millimeter
targeting accuracy (Nowacki et al., 2017), deviations of about
2 mm or more were reported for other surgical approaches
(Guo et al., 2007; Lee et al., 2018). These deviations increase the
likelihood of stimulation-induced side effects, which can affect up
to 50% of implanted patients (Volkmann et al., 2009).
Directional stimulation with segmented leads is a promising
approach to address this issue (Contarino et al., 2014; Pollo et al.,
2014; Nguyen et al., 2019a). It can reduce undesired activation
of adjacent structures such as the internal capsule, and indeed,
it has demonstrated higher side effect thresholds than classical
omnidirectional stimulation in implanted patients (Steigerwald
et al., 2016; Dembek et al., 2017). Directional stimulation may
further be leveraged to target very specific and clinically effective
regions of the subthalamic nucleus, also known as “sweet spots”
obtained from probabilistic mapping (Horn et al., 2017; Dembek
et al., 2019; Nguyen et al., 2019b).
These regions are associated with abnormal
electrophysiological activity recorded through local field
potentials (LFPs). Specifically, spectral analysis has highlighted
excessive oscillations in the beta band between 13 and 35 Hz.
These were found to be correlated with the severity of motor
symptoms (Hammond et al., 2007; Chen et al., 2010; Little et al.,
2012) and were reduced by effective DBS (Kühn et al., 2008).
With segmented leads, stimulation in the direction with the
highest spectral power in the beta frequency band was associated
with better motor improvement (Bour et al., 2015) or a wider
therapeutic window (Tinkhauser et al., 2017a). Both these studies
recorded LFP intraoperatively with patients at rest. However,
motor tasks have been shown to decrease the power in the
beta frequency band (Kühn et al., 2004) or modulate specific
sub-bands (Tinkhauser et al., 2019) and may, therefore, provide
additional guidance on identifying the best stimulation direction.
Here, we report directional LFPs from the subthalamic
nucleus. Local field potentials were recorded intraoperatively
with a segmented lead in two conditions: (i) with patients at rest
and (ii) with passive movement of the patient’s arm. By analyzing
the spectral power in the total beta frequency band and its sub-
bands, we investigated whether and how the resting and moving
conditions are indicators of the best stimulation direction. As
a first step, this could guide the complex programming of
directional DBS (ten Brinke et al., 2018).
MATERIALS AND METHODS
Patient Recruitment, Surgical Procedure,
and Intraoperative Assessment
Four patients with Parkinson’s disease were included in this study
at the University Hospital of Bern. Two patients were female;
ages ranged from 33 to 70 years with a median age of 62 years.
The local ethics committee and the Swiss Competent Authority
approved the study protocol, which conformed to the Good
Clinical Practice guidelines and the International Organization
for Standardization 14155 standard. All four patients provided
written informed consent and represented a subset of our
previous study (Pollo et al., 2014), who in addition agreed
to LFP recordings. These were patients 9, 11, 12, and 13 in
the previous study and were relabeled here as patients 1–
4 (Table 1).
The patients were implanted under local anesthesia with a
stereotactic frame (Leksell frame, Elekta, Stockholm, Sweden).
For surgical planning, preoperative magnetic resonance images
were coregistered to stereotactic computer tomography images.
They received implantation in both hemispheres, but testing
with the segmented lead was performed only in the first
hemisphere operated on.
Firstly, microelectrode recording and macrostimulation
were performed to refine the location of the subthalamic
nucleus and to identify the target trajectory and depth for
permanent implantation.
Secondly, the segmented lead was inserted (directSTN Acute,
Aleva Neurotherapeutics, Lausanne, Switzerland, Figure 1A).
This lead was specifically designed for the intraoperative study
and featured two levels of directional electrodes (electrode
surface area of 1 mm2). The lead was placed in the same
trajectory as intended for the permanent lead, and the distal
level of directional electrodes was lowered to the same
depth as in the previous step of macrostimulation. The
segmented lead’s first directional electrode at 0◦ was oriented
toward medial, the second electrode at 120◦ toward antero-
lateral, and the third electrode at 240◦ toward postero-lateral.
The surgeon used a marker line at 0◦ along the lead for
orientation and inserted the lead without extra rotation. The
depth of the segmented lead was intraoperatively confirmed
with fluoroscopy.
Thirdly, the segmented lead was used for intraoperative LFP
recording. The three directional electrodes on the distal level
were used to record LFP simultaneously for 30 s. The electrical
return was set to the cannula, 19 mm away from the recording
contacts (pseudomonopolar montage). The LFPs were recorded
for a resting condition (i.e., patient at rest) and then a passive
moving condition (i.e., extension and flexion of the elbow)
after a short break of 5 s. However, this study did not include
instrumentation to synchronize movement and LFP recording.
The LFPs were acquired with the Medtronic Leadpoint system
(Medtronic, Fridley, MN, United States) with a sampling rate of
24 kHz for each direction. The Leadpoint system was additionally
configured to apply a band-pass filter between 5 Hz and 5 kHz,
and a notch filter at 50 Hz. Inserting the segmented lead
after microelectrode recording should reduce the impact of
a stun effect on the LFP recording (Chen et al., 2006). In
addition, we performed LFP recordings at one depth only, and
therefore, the impact of a stun effect should be similar for the
three directions.
Fourthly, the segmented lead was used for intraoperative
clinical testing. It was connected to an external neurostimulator
with multiple independent current-driven sources (Osiris
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TABLE 1 | Ranking of directions as defined by therapeutic window for the four patients.
Patient 1st best direction (mA) 2nd best direction (mA) 3rd best direction (mA)
1 Antero-lateral (2.7, 0.5–3.2) Medial (2.7, 0.5–3.2) Postero-lateral (2.1, 0.4–2.5)
2 Antero-lateral (2.1, 0.4–2.5) Postero-lateral (1.3, 0.6–1.9) Medial (1.3, 0.9–2.2)
3 Medial (2.4, 1.0–3.4) Antero-lateral (1.6, 1.7–3.3) Postero-lateral (0.7, 1.6–2.3)
4* Medial (2.7, 0.6–3.3) Antero-lateral (2.4, 0.6–3.0) Postero-lateral (1.7, 0.6–2.3)
The first value in brackets is the therapeutic window, followed by therapeutic current threshold and side effect threshold, all in mA. Rigidity was the main symptom
for all patients.
*Therapeutic current thresholds were identical for this patient. When ranking the directions by therapeutic current threshold, the therapeutic window was used as a
tiebreaker (i.e., larger window ranks higher).
FIGURE 1 | Segmented lead and recording of directional local field potentials. (A) The segmented lead had two levels of directional electrodes and two levels of ring
electrodes. Only the most distal level of directional electrodes toward the tip was used for recording and stimulation. (B) Example of filtered traces and power
spectral densities (PSD) from Patient 2 for the three directions.
Stimulators, Model 504196, Inomed GmbH, Emmendingen,
Germany). Each of the three directional electrodes was tested
with monopolar stimulation. The stimulation pulses were
cathodic-first with a pulse width of 90 µs and frequency
of 130 Hz. A metal plate was used as a distant current
return and placed in the subclavicular area, similar to
the area for the permanent implantable pulse generator.
A separate operator configured the stimulation direction and
current amplitude, and thus, the patient and the clinician
assessing the clinical effects of stimulation were blinded to the
stimulation configuration.
The clinical effects were assessed based on the rigidity of
the patient’s hand. The assessment was performed by the same
experienced neurologist for all four patients. The stimulation
current was increased in 0.2 mA steps to determine the
therapeutic current threshold, i.e., the lowest stimulation current
that resulted in no rigidity. Then, the stimulation current was
further increased to determine the side effect current threshold,
where a sustained side effect such as paresthesia, dysarthria, or
focal muscular contraction was observed. The difference between
the two thresholds was defined as the therapeutic window and
was used to rank the directions. The direction with the largest
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FIGURE 2 | Power spectral densities and power in the resting condition. (A) Power spectral densities for the four patients highlighting the direction with peak
spectral density (dotted line and filled triangle). (B) Power for the four patients in the total beta band and its sub-bands. The bars are ordered by 1st, 2nd, and 3rd
best direction for each patient (Table 1). The error bars represent the 95% confidence interval. A, antero-lateral; M, medial; P, postero-lateral directions.
window was ranked as 1st best direction and so on. When
directions had the same therapeutic window, the direction with
the lower therapeutic current threshold was ranked higher.
Therapeutic current thresholds, side effect current thresholds,
and therapeutic windows for all patients and directions are listed
in Table 1.
Finally, the segmented lead was removed after clinical
testing, and the permanent lead was inserted using the same
guide tube.
Data Analysis
In our analysis, we first analyzed the spectral power of
LFP recordings for the two conditions. Then, the spectral
power was used by different algorithms to predict the ranking
of directions.
The LFP recordings were analyzed post hoc with Matlab
2019b (MathWorks, Natick, MA, United States). Firstly, the 30-s
recordings were downsampled to 375 Hz and visually inspected
for artifacts. The resting recording for patient 3 was shortened
to the period from 0 to 25 s due to an artifact at the end. All
other recordings were processed at full length. Power spectral
densities were then computed with the Welch method with
25% overlap and a spectral frequency resolution of 0.5 Hz.
The spectral power of the beta band was calculated as the area
under the density curve between 13 and 35 Hz (Figure 1B).
Furthermore, we calculated the power in three sub-bands: low
beta (13–20 Hz), high beta (20.5–35 Hz), and peak beta, i.e.,
2 Hz around the beta peak (Tinkhauser et al., 2017a, the peak
was determined by the maximum power spectral density across
the three directions). The spectral power was normalized to
the average power in the beta frequency band across the three
recorded directions (Geng et al., 2018). This normalization was
done separately for the resting and moving conditions. For the
comparison of movement condition versus resting condition, the
normalization factor from the moving condition was applied to
both conditions.
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FIGURE 3 | Power spectral densities and power in the passive moving condition. (A) Power spectral densities for the four patients highlighting the direction with
peak spectral density (dotted line and filled triangle). The peaks shifted slightly in patients 1, 2, and 4 compared to the resting condition. (B) Power for the four
patients in the total beta band and its sub-bands. The bars are ordered by 1st, 2nd, and 3rd best direction for each patient (Table 1). The error bars represent the
95% confidence interval. A, antero-lateral; M, medial; P, postero-lateral directions.
We benchmarked different algorithms to predict the ranking
of directions. The actual ranking was determined from the
intraoperative testing as described above, i.e., the direction
with the largest therapeutic window was ranked as 1st
best direction and so on. In addition, we also tested the
therapeutic current thresholds for the ranking. The direction
with the lowest threshold was ranked as 1st best direction
and so on. The predicted ranking was determined from the
spectral power, i.e., the direction with the highest spectral
power was predicted as 1st best direction and so on. For
therapeutic current thresholds, initial prediction performances
were low, and we additionally tested the reverse order,
i.e., the lowest spectral power was predicted as 1st best
direction and so on. The different algorithms were based
on the spectral power for the moving condition and resting
condition, as well as the ratio of moving-to-resting and for
the four sub-bands, total, low, high, and peak beta. Confusion
matrices were used to illustrate the prediction performance
of an algorithm.
RESULTS
Power Spectral Densities for Different
Conditions and Directions
We recorded directional LFPs through a segmented lead
in four Parkinson’s disease patients undergoing subthalamic
nucleus implantation.
In the resting condition, the power spectral densities showed
different profiles for each patient (Figure 2A). Patient 1 had
a spectral peak in the high beta band; and patients 2, 3, and
4 had a spectral peak in the low beta band (27, 18, 16.5,
and 20 Hz, respectively). The direction with the peak spectral
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FIGURE 4 | Ratio of moving-to-resting power for the different patients, directions, and sub-bands. The bars are ordered by 1st, 2nd, and 3rd best direction for each
patient (Table 1). The dashed horizontal line indicates no change between moving and resting. A, antero-lateral; M, medial; P, postero-lateral directions.
density was antero-lateral for patients 1 and 2 and medial for
patients 3 and 4.
Also in the resting condition, we observed differences in
power for the three directions (Figure 2B). The most noticeable
differences were observed for patient 2. For this patient, the
antero-lateral direction had the highest power in the total beta
band followed by the postero-lateral and medial directions.
This directional ranking was consistent across the sub-bands.
For the other patients, differences in power were less marked
between the directions. Generally, the direction with the peak
spectral density had also the most power across the total beta
band. None of the sub-bands emphasized directional differences
in particular.
In the passive moving condition, the power spectral densities
remained patient-specific and were accompanied by a slight shift
in spectral peaks (Figure 3A). Now, patients 1, 2, and 4 had
spectral peaks in the high beta band, whereas patient 3’s spectral
peak remained in the low beta band (25, 22, 20.5, and 15.5 Hz,
respectively). The directions with the peak spectral density were
the same as in the resting condition, except for patient 1 where a
change from antero-lateral to medial direction was observed.
In terms of power (Figure 3B), directional trends in the
moving condition were similar to the ones in the resting
condition. The most noticeable directional differences were
again observed for patient 2. In patient 1, the power for the
medial direction became more prominent compared to the
resting condition.
Calculating the power ratio of moving-to-resting condition
showed some changes in the beta band and its sub-bands
(Figure 4). The ratios for the total beta band indicated only minor
changes between the conditions (i.e., ratio of 1). The ratios for the
low beta band indicated a decrease in power in the movement
condition (i.e., ratio <1). This decrease was most marked for
patients 1 and 3. The ratios for the high beta band, on the other
hand, indicated an increase in power in the movement condition
(i.e., ratio >1). This was most noticeable in patients 2 and 4. The
power in the peak beta band indicated an increase in power in
the movement condition for Patient 1 and only small changes
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FIGURE 5 | Confusion matrices showing the classification performance of different ranking algorithms. (A) Predicting the ranking of directions based on the spectral
power in the total beta band of the moving condition. The predicted ranking was done from highest to lowest spectral power. The actual ranking was defined by the
therapeutic window. Elements on the diagonal from top left to bottom right illustrate correctly classified directions (green shaded), whereas other elements were
incorrectly classified (red shaded). In total, 83.3% of directions were classified correctly. (B) Similar to panel (A) but for the resting condition. (C) Predicting the
ranking of directions as defined by the therapeutic current threshold. The prediction was based on the spectral power ratio moving-to-resting in the total beta band,
but from lowest to highest spectral power ratio (cf. Table 2).
for the other patients. In terms of directions, the ratios did not
show a tendency.
Spectral Power to Predict Direction
Ranking
For the therapeutic window, the spectral power in the total
beta band was the best predictor to rank the three directions.
Specifically, ranking the directions from highest to lowest spectral
power in that band generally matched the ranking of 1st, 2nd, and
3rd best direction. Both the moving condition and the resting
condition were similarly predictive and classified 83.3% of the
directions correctly (Figures 5A,B). For instance, the direction
with the highest spectral power in the total beta band matched
the 1st best direction in three out of four patients.
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TABLE 2 | Classification performance of the different algorithms.
Algorithm Correctly
classified (%)
Incorrectly
classified (%)
Algorithm Correctly
classified (%)
Incorrectly
classified (%)
Ranking high-to-low spectral power Ranking high-to-low spectral power
Window, moving Current, moving
Total beta 83.3 16.7 Total beta 16.7 83.3
Low beta 58.3 41.7 Low beta 16.7 83.3
High beta 66.7 33.3 High beta 25 75
Peak beta 58.3 41.7 Peak beta 16.7 83.3
Window, resting Current, resting
Total beta 83.3 16.7 Total beta 41.7 58.3
Low beta 66.7 33.3 Low beta 50 50
High beta 41.7 58.3 High beta 25 75
Peak beta 58.3 41.7 Peak beta 16.7 83.3
Window, moving-to-resting Current, moving-to-resting
Total beta 41.7 58.3 Total beta 25 75
Low beta 25 75 Low beta 41.7 58.3
High beta 33.3 66.7 High beta 16.7 83.3
Peak beta 33.3 66.7 Peak beta 16.7 83.3
Ranking low-to-high spectral power
Current, moving
Total beta 66.7 33.3
Low beta 66.7 33.3
High beta 58.3 41.7
Peak beta 66.7 33.3
Current, resting
Total beta 41.7 58.3
Low beta 58.3 41.7
High beta 33.3 66.7
Peak beta 41.7 58.3
Current, moving-to-resting
Total beta 83.3 16.7
Low beta 66.7 33.3
High beta 41.7 58.3
Peak beta 66.7 33.3
Best performing classifiers are set in bold and are also shown in Figure 5. Left part of the table using the therapeutic window for the actual ranking (larger window—higher
ranking); right part of the table using the therapeutic current threshold for the actual ranking (lower threshold—higher ranking).
For the therapeutic current threshold, a different ranking
algorithm was the best predictor. In contrast to the ranking above,
we found ranking the directions from lowest to highest spectral
power to be more predictive of the therapeutic current threshold.
Specifically, the spectral power ratio of moving-to-resting from
the total beta band was most predictive and classified 83.3% of
the directions correctly (Figure 5C). For instance, the direction
with the lowest spectral power ratio in that band matched the 1st
best direction in three out of four patients. The percentages of
correctly and incorrectly classified directions are summarized for
all conditions and sub-bands in Table 2.
DISCUSSION
This study investigated directional LFPs from the subthalamic
nucleus and their potential to determine clinically effective
stimulation directions. The study emphasized three findings.
Firstly and most importantly, we found that ranking directions
from highest to lowest spectral power in the total beta band
generally mirrored the ranking of best stimulation directions
as defined by therapeutic window. For instance, the direction
with the highest spectral power was also the 1st best stimulation
direction in three out of four patients. Our finding is in agreement
with previous studies that recorded directional LFPs with patients
at rest. These reported better motor improvement or wider
therapeutic window for stimulation in the direction of highest
beta activity (Bour et al., 2015; Tinkhauser et al., 2017a). The
direction with the highest beta activity may point toward a
highly pathological cell cluster in the subthalamic nucleus that
limits information coding in the motor network of the brain
(Little and Brown, 2014). Stimulation in that direction may
suppress beta activity as has been shown with omnidirectional
leads (Kühn et al., 2008) and segmented leads (Bour et al.,
2015). This in turn may release information flow in the
motor network as demonstrated in computational simulations
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(Humphries et al., 2018; Müller and Robinson, 2018) and thus
improve motor symptoms.
Interestingly, to predict the ranking of directions as defined
by therapeutic current threshold required a different ranking
algorithm. This algorithm ranked directions from lowest to
highest spectral power in the total beta band and used the
power ratio of moving-to-resting. A lower spectral power in
one direction may indicate a relatively smaller pathological cell
cluster compared to the other directions, which in turn may
require a lower current amplitude to release information flow
in the motor network. Furthermore, a lower spectral power
ratio of moving-to-resting suggests that this direction with the
smaller pathological cell cluster is more sensitive to movement
modulation than the other directions.
Secondly, our main finding about ranking based on the total
beta band was valid both for the resting condition and for
the moving condition. With respect to spectral power, there
was no clear difference in the total beta band between the
resting and moving conditions (Figures 4, 5). Two patients
showed a decrease in the low beta band in response to
movement, whereas the two other patients showed an increase
in the high beta band. With active movement, beta activity
has been found to decrease prior to movement and increase
again after movement (Levy et al., 2002; Kühn et al., 2004).
With passive movement like in this study, beta activity has
been found to be movement-locked with a decrease at the time
of maximum angle of the elbow (Connolly et al., 2015). Our
results are in accordance with these findings, even if the protocol
of this exploratory study did not include synchronization of
LFP recording and movement of the joint. Thus, we were
not able to precisely analyze temporal characteristics, which
may have added directional information as has been recently
suggested in non-human primates (Zhang et al., 2018) or patients
(Tinkhauser et al., 2019).
Thirdly, we analyzed three beta sub-bands and observed beta
band profiles that were patient-specific with spectral peaks in the
low or high beta band. The beta band was divided into a low and
a high beta band previously to discuss different influences (Priori
et al., 2004). Spectral peaks in the low beta band were significantly
reduced by acute antiparkinsonian medication (levodopa), while
activity in the high beta band was affected by movement (Kühn
et al., 2004; Tinkhauser et al., 2019). The divergence of peaks in
our cohort may help explain why none of the sub-bands provided
additional directional information. The divergence also seems to
agree with a previous study suggesting that the beta band profile
was a patient-specific “fingerprint” (Bronte-Stewart et al., 2009).
This view has been recently supported by a computational study
of LFPs (Maling et al., 2018).
Several limitations of our study are noteworthy. Our
recordings were performed at one depth only due to
intraoperative constraints, but the beta band profile is known
to change along the subthalamic nucleus (Bour et al., 2015;
Horn et al., 2017; Geng et al., 2018). We only tested patients
with rigidity-dominant Parkinson’s disease, although LFPs were
reported to be symptom-specific (Fernández-García et al., 2017;
Telkes et al., 2018). Our exploratory study examined the averaged
power in the beta band across 30-s recordings. It did not analyze
beta bursts that may reveal further information about the best
stimulation direction and may be additionally relevant for
adaptive DBS to switch directions or modulate the stimulation
amplitude (Little et al., 2016; Tinkhauser et al., 2017b, 2018).
Future studies therefore need to shed more light on the beta band
or beta burst profile of Parkinson’s disease. In the meantime,
the total beta band may be the most robust indicator of best
stimulation direction.
In summary, directional LFPs recorded with segmented leads
support the hypothesis that spectral power may be indicative
of the best stimulation direction. More specifically, the spectral
power in the total beta band was the best predictor of direction
ranking in our small cohort. This preliminary finding needs to
be confirmed in a future study with a larger patient cohort.
A refined analysis of the movement and resting conditions
should provide a better understanding of the patient-specific
beta band profile.
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